Jupiter Neurosciences Prices $2M Offering and Draws $851K More from Yorkville SEPA
JUNS sits 18% above its 52-week low of $4.56 on elevated volume (54× avg).
Summary
Jupiter Neurosciences priced a $2M registered direct offering at $6.50/share and separately drew $851K from its Yorkville SEPA, adding to dilution pressure ahead of an August 25 Nasdaq compliance deadline.
Key Events · Financing and Capital Events · JUNS
-
$2M Registered Direct Offering Priced
307,692 shares at $6.50 per share for gross proceeds of approximately $2.0 million; net proceeds of about $1.74 million after placement agent fees.
-
Additional $851K SEPA Drawdown
Between August 14-21, 2026, the company sold 107,920 shares to Yorkville under the SEPA for $851,194 at 97% of the lowest daily VWAP.
-
Placement Agent Terms
D. Boral Capital LLC receives a 7.0% cash fee on gross proceeds plus expense reimbursement up to $75,000.
-
Nasdaq Deadline and Going Concern
Company must regain Nasdaq compliance by August 25, 2026 — one day after expected closing — and carries a going concern warning from its August 14, 2026 10-Q.
Analysis · JUNS · Life Sciences
Jupiter Neurosciences priced a $2 million registered direct offering at $6.50 per share, netting about $1.74 million after placement agent fees. The 8-K also reveals an additional $851,194 SEPA drawdown to Yorkville between August 14-21, bringing total dilution from both transactions to roughly 307,692 shares plus 107,920 shares. The company faces a Nasdaq delisting deadline of August 25, 2026 — one day after the expected closing — and has a going concern warning from its most recent 10-Q. The 30-day standstill and lock-up agreements temporarily restrict further issuance, but the SEPA remains available for future draws.
How filings like this one have moved
In the 30 days to Aug 24, 2026, 29.4% of the 2796 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.03%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, JUNS was trading at $5.38 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.8M. The 52-week trading range was $4.56 to $137.96. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.